Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Puliafito

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Hematology. American Society of Hematology. Education Program|December 5, 2025
Choosing the optimal maintenance strategy in multiple myelomaBenjamin Puliafito, Diana Cirstea, Noopur Raje
BMJ Case Reports|June 22, 2022
Secondary B-cell acute lymphoblastic leukaemia in a patient with multiple myelomaBenjamin Puliafito, David Oveisi, Christina Fanous, et al.
Best Practice & Research. Clinical Haematology|September 7, 2025
Bispecific T-cell engager therapy for multiple myelomaDiana Cirstea, Benjamin Puliafito, Bridget E Kim, et al.
Bone Marrow Transplantation|October 19, 2022
Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell supportTarek H Mouhieddine, Erin Moshier, Santiago Thibaud, et al.
Journal of Medical Genetics|September 9, 2019
High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriersMaribel González-Acosta, Fátima Marín, Benjamin Puliafito, et al.
Leukemia|January 27, 2025
International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myelomaLuciano J Costa, Rahul Banerjee, Hira Mian, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Hematology. American Society of Hematology. Education Program|December 5, 2025
Choosing the optimal maintenance strategy in multiple myelomaBenjamin Puliafito, Diana Cirstea, Noopur Raje
BMJ Case Reports|June 22, 2022
Secondary B-cell acute lymphoblastic leukaemia in a patient with multiple myelomaBenjamin Puliafito, David Oveisi, Christina Fanous, et al.
Best Practice & Research. Clinical Haematology|September 7, 2025
Bispecific T-cell engager therapy for multiple myelomaDiana Cirstea, Benjamin Puliafito, Bridget E Kim, et al.
Bone Marrow Transplantation|October 19, 2022
Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell supportTarek H Mouhieddine, Erin Moshier, Santiago Thibaud, et al.
Journal of Medical Genetics|September 9, 2019
High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriersMaribel González-Acosta, Fátima Marín, Benjamin Puliafito, et al.
Leukemia|January 27, 2025
International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myelomaLuciano J Costa, Rahul Banerjee, Hira Mian, et al.
Pageof 1